Related Experiment Videos
Sedation and analgesia in children with developmental disabilities and neurologic disorders
Todd J Kilbaugh1, Stuart H Friess, Ramesh Raghupathi
1Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Insights
Pediatric sedation and analgesia for children with developmental disabilities and neurologic disorders carry increased respiratory risks. This review examines recent studies and commonly used central nervous system medications.
Area of Science:
- Pediatric Anesthesiology
- Neurology
- Developmental Pediatrics
Background:
- Sedation and analgesia are increasingly utilized in pediatric care for diagnostic and therapeutic procedures.
- Children with developmental disabilities and neurologic disorders often require these interventions.
- These conditions include autism, epilepsy, stroke, and traumatic brain injury.
Purpose of the Study:
- To review recent studies on the heightened risk of respiratory complications in this patient group.
- To enhance understanding of commonly used sedatives and analgesics affecting the central nervous system.
Main Methods:
- Literature review of recent studies.
- Analysis of sedative and analgesic medication profiles relevant to pediatric central nervous system effects.
Main Results:
- Studies indicate a significant increase in respiratory complications following sedation and analgesia in children with developmental disabilities and neurologic disorders.
- Commonly used medications impact the central nervous system, influencing respiratory function.
Conclusions:
- Healthcare providers must be aware of the elevated respiratory risks associated with pediatric sedation and analgesia in this population.
- Careful selection and monitoring of sedatives and analgesics are crucial for patient safety.
Abstract:
Sedation and analgesia performed by the pediatrician and pediatric subspecialists are becoming increasingly common for diagnostic and therapeutic purposes in children with developmental disabilities and neurologic disorders (autism, epilepsy, stroke, obstructive hydrocephalus, traumatic brain injury, intracranial hemorrhage, and hypoxic-ischemic encephalopathy). The overall objectives of this paper are (1) to provide an overview on recent studies that highlight the increased risk for respiratory complications following sedation and analgesia in children with developmental disabilities and neurologic disorders, (2) to provide a better understanding of sedatives and analgesic medications which are commonly used in children with developmental disabilities and neurologic disorders on the central nervous system.
Related Concept Videos
Parenteral Anesthetics: Overview
Stages of General Anesthesia
Skeletal Muscle Relaxants: Therapeutic Uses
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
CNS Depressants: Barbiturates and Benzodiazepines